Search - tctmd.com

Displaying 521 - 540 of 1322

Sort: Relevancy | Date

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Daily News

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

Todd Neale

November 07, 2019

News Daily News

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Caitlin E. Cox

November 04, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Caitlin E. Cox

October 24, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT 2019

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Presenter: Philippe Genereux

September 29, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Advertisement

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Women More Likely Than Men to Develop Heart Failure After STEMI

TCTMD’s Top 10 Most Popular Stories for October 2019

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Repeat Target-Lesion PCI: An Option for Public Reporting?

Sex-Based Nuances Seen in iFR and FFR Testing: DEFINE-FLAIR

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

Recurrent Events Common Among Young Patients With CAD

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

TCTMD’s Top 10 Most Popular Stories for September 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content